NasdaqGM - Nasdaq Real Time Price USD
Entrada Therapeutics, Inc. (TRDA)
8.25
+0.24
+(3.00%)
As of 3:14:19 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.83 | -0.89 | -3.15 | -4.16 |
| Low Estimate | -0.98 | -1.05 | -3.65 | -5.1 |
| High Estimate | -0.72 | -0.76 | -2.57 | -2.97 |
| Year Ago EPS | 1.55 | -0.35 | 1.68 | -3.15 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 2 |
| Avg. Estimate | 8.31M | 8.06M | 44.42M | 28.21M |
| Low Estimate | 4.5M | 4.5M | 34.06M | -- |
| High Estimate | 12M | 12M | 62.87M | 56.42M |
| Year Ago Sales | 94.69M | 19.57M | 210.78M | 44.42M |
| Sales Growth (year/est) | -91.22% | -58.80% | -78.93% | -36.49% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.33 | -0.62 | -0.66 | -0.77 |
| EPS Actual | 1.55 | -0.35 | 0.03 | -0.42 |
| Difference | 1.22 | 0.28 | 0.69 | 0.36 |
| Surprise % | 369.70% | 44.00% | 104.52% | 45.81% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.83 | -0.89 | -3.15 | -4.16 |
| 7 Days Ago | -0.78 | -0.84 | -2.99 | -4.03 |
| 30 Days Ago | -0.83 | -0.9 | -3.44 | -3.87 |
| 60 Days Ago | -0.72 | -0.76 | -2.94 | -3.24 |
| 90 Days Ago | -0.74 | -0.76 | -3.02 | -2.51 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TRDA | -153.55% | -155.71% | -287.80% | -31.96% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/20/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/4/2025 |
| Initiated | Roth MKM: Buy | 12/5/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/6/2024 |
Related Tickers
TCRX TScan Therapeutics, Inc.
1.2300
-0.81%
PEPG PepGen Inc.
1.5300
+2.68%
KRRO Korro Bio, Inc.
16.34
+4.01%
HOOK HOOKIPA Pharma Inc.
1.6800
+10.53%
NRIX Nurix Therapeutics, Inc.
9.88
+3.89%
RNA Avidity Biosciences, Inc.
31.17
+3.14%
KOD Kodiak Sciences Inc.
4.0800
+9.97%
TYRA Tyra Biosciences, Inc.
9.97
+3.00%
PBYI Puma Biotechnology, Inc.
3.6240
+1.23%
ELVN Enliven Therapeutics, Inc.
17.26
+2.43%